This article is educational and does not replace medical advice. Prescription medication requires review by a licensed clinician and, when appropriate, a valid prescription. Compounded medications are not FDA-approved, and the FDA does not verify their safety, effectiveness or quality before marketing. Treatment eligibility is an individual clinical decision.

Disclosure: we may earn a commission if you use certain links on this page. Compensation does not change our published methodology, scoring, or editorial conclusions.

Written by Kim Callender, NP, FNP-BC·Published July 12, 2026·Last reviewed August 4, 2026·Prices verified August 4, 2026·Methodology v1.0

This page is maintained. Prices are re-read at source and dated; evidence is checked against the published trial. Newest across the site: news · research · corrections.

NexLife vs Eden: pricing, doses and services compared

Which is better for whom?

NexLife and Eden serve different priorities. NexLife: NexLife bundles medication, clinician care, laboratory review, support and expedited shipping into one flat price with n… Eden: Flat compounded pricing at every dose — $99 semaglutide or $199 tirzepatide — but an Eden Membership is REQUIRED for any… There is no universal winner — the right choice depends on whether you optimize for lowest starter price, flat dose pricing, or bundled clinical services. Figures reflect status as of July 12, 2026.

The $449 tier has a condition. LillyDirect prices Zepbound at $299 (2.5 mg), $399 (5 mg) and $449 (7.5–15 mg) a month under its self-pay programme. The $449 rate on 7.5 mg and above holds only if you refill within 45 days of your previous delivery. Miss that window and the refill is charged at the standard rate — reported at $499 to $699 depending on dose — before the programme rate resumes on the next order. Re-read at source 4 August 2026.

How do they compare, field by field?

Price comparison — NexLife vs Eden, July 12, 2026

NexLifeEden

Where a program holds one flat price across doses, its two bars are equal. Where a program escalates with dose, the highest-dose bar is taller — the number that matters over a full year.

NexLife vs Eden — side by side, July 12, 2026
Factor	NexLife	Eden
Starting price	$147/mo (microdose) Verified	$198/mo total (sema) Reported — pending verification
Renewal price	$186/mo full-dose (12-mo); $215 month-to-month Verified	$298 total (tirz) Reported — pending verification
Highest-dose price	Flat — no dose-based increase Verified	Flat at all doses on compounded Reported — pending verification
Membership	$0 Verified	$99/mo REQUIRED ($39 first month) Reported — pending verification
Labs	Lab review included Verified	Pending research Reported — pending verification
Shipping	Included (expedited) Verified	Pending research Reported — pending verification
Commitment	12-month or month-to-month Verified	Monthly Reported — pending verification
Pharmacy	Network disclosed: Red Rock, Hallandale, Absolute, Empower, DIRx (licences not yet independently verified by us) Verified	Not independently verified Reported — pending verification
Clinician	Medical Director: Adam Kennah, MD (NPI 1144260043, provider-supplied) Verified	Clinician network Reported — pending verification
States	All 50 states, synchronous and asynchronous visits Verified	Pending research Reported — pending verification

Which one wins on each decision factor?

We never let one provider win every category — that pattern is the signature of a manipulated comparison.

Winner by decision factor
Decision factor	Better fit
Lowest advertised starter price	NexLife
Best all-inclusive value	NexLife
Clearest pharmacy disclosure	Depends / tie
Best month-to-month flexibility	NexLife

NexLife: who it fits

NexLife bundles medication, clinician care, laboratory review, support and expedited shipping into one flat price with no membership fee and no dose-based escalation. Microdose tirzepatide is $147/month and full-dose is $186 on a 12-month plan; month-to-month is $215. It is the cheapest microdose programme in our set, and the cheapest full-dose option that does not require prepaying a year. Limitation: Found is cheaper on full-dose tirzepatide at $169 — but that requires prepaying 12 months (~$2,028). Oak Longevity is cheaper on semaglutide at $133. NexLife offers no brand pathway and no insurance coordination. Full NexLife review →

Eden: who it fits

Flat compounded pricing at every dose — $99 semaglutide or $199 tirzepatide — but an Eden Membership is REQUIRED for any medication, at $99/month after a $39 first month. True totals are $198 and $298. Limitation: <b>Eden resells brand Zepbound at $1,399/month and brand Wegovy at $1,695/month.</b> The manufacturers sell the identical drugs direct for $299–$449 and $149–$349. Check LillyDirect and NovoCare before buying brand through Eden. Full Eden review →

Frequently asked questions

Is NexLife or Eden cheaper?

On starting price: NexLife is $147/mo (microdose) and Eden is $198/mo total (sema). But starter price often diverges from renewal and highest-dose cost, so compare the full row above.

How were these figures verified?

Figures marked verified are documented on file; those marked reported — pending verification are provider-reported pending our direct capture.

Sources

Both providers' pricing and terms pages, captured July 12, 2026.
Our price-normalization methodology.
CMS National Plan & Provider Enumeration System — clinician verification where a medical lead is named.

Spotted an error? Submit a correction.

How the dates on this page work. Manufacturer self-pay prices — NovoCare and LillyDirect — were re-read on the manufacturers’ own published price guides on 4 August 2026. Figures captured from third-party provider websites carry the date we read that provider’s page, which may be earlier; where it is, the row says so. We do not restamp a figure we have not re-read.